<p><h1>Drug Eluting Balloon for Peripheral Artery Disease Market Size, Market Trends, and Growth Outlook forecasted for period from 2024 to 2031</h1></p><p><strong>Drug Eluting Balloon for Peripheral Artery Disease Market Analysis and Latest Trends</strong></p>
<p><p>A Drug Eluting Balloon (DEB) is a medical device used in the treatment of Peripheral Artery Disease (PAD). It is designed to deliver anti-proliferative drugs directly to the site of arterial blockage, helping to prevent restenosis and improve long-term outcomes. The DEB for PAD market is expected to witness substantial growth in the coming years, with a projected CAGR of 6.5% during the forecast period.</p><p>Some of the key factors driving the growth of the DEB for PAD market include the increasing prevalence of PAD, rising awareness about minimally invasive treatment options, and advancements in technology leading to the development of more effective and advanced drug-eluting balloons. Additionally, the growing geriatric population and the rising demand for better treatment options are also contributing to the market growth.</p><p>Furthermore, the adoption of DEBs for PAD is expected to rise as healthcare providers and patients increasingly favor minimally invasive treatment options that offer better outcomes and shorter recovery times. The market is witnessing various trends such as product innovations, strategic collaborations, and expansions by key players to gain a competitive edge and expand their market presence in the rapidly growing DEB for PAD market.</p></p>
<p><strong>Get a Sample PDF of the Report:&nbsp;</strong> <a href="https://www.reliableresearchreports.com/enquiry/request-sample/1671438">https://www.reliableresearchreports.com/enquiry/request-sample/1671438</a></p>
<p>&nbsp;</p>
<p><strong>Drug Eluting Balloon for Peripheral Artery Disease Major Market Players</strong></p>
<p><p>Cook Group is a prominent player in the drug-eluting balloon for peripheral artery disease market. The company has a strong presence in the market with a wide range of products catering to the needs of patients with peripheral artery disease. Cook Group has shown consistent growth in the market due to its focus on innovation and research. The company's future growth prospects look promising as it continues to invest in research and development to come up with advanced solutions for peripheral artery disease.</p><p>Medtronic is another key player in the market with a significant market share. The company has a diverse product portfolio in the peripheral artery disease segment, including drug-eluting balloons. Medtronic's market growth has been steady, thanks to its strong distribution network and brand reputation. The company is expected to witness further growth in the future with its focus on expanding its product line and entering new markets.</p><p>In terms of revenue, Medtronic reported sales revenue of $30.56 billion in the fiscal year 2020, showcasing its strong financial performance and market position. Cook Group had sales revenue of $1.8 billion in 2020, reflecting its substantial presence in the market.</p><p>Overall, the drug-eluting balloon for peripheral artery disease market is highly competitive, with players like Cook Group, Medtronic, and others vying for market share. These companies are expected to witness steady growth in the future as they continue to innovate and introduce advanced solutions for patients with peripheral artery disease. As the market size for these products continues to expand, these players are well-positioned to capitalize on the opportunities presented in the market.</p></p>
<p>&nbsp;</p>
<p><strong>What Are The Key Opportunities For Drug Eluting Balloon for Peripheral Artery Disease Manufacturers?</strong></p>
<p><p>The global drug-eluting balloon for peripheral artery disease market is expected to witness significant growth in the coming years due to the rising prevalence of peripheral artery disease and increasing adoption of minimally invasive treatment options. Key factors driving market growth include technological advancements in drug-eluting balloons, increasing healthcare expenditure, and growing awareness among patients. Additionally, favorable reimbursement policies and a shift towards outpatient procedures are likely to fuel market expansion. Despite challenges such as high costs and lack of skilled healthcare professionals, the market is projected to experience steady growth, with a focus on innovation and strategic collaborations.</p></p>
<p><strong>Inquire or Share Your Questions If Any Before Purchasing This Report:</strong> <a href="https://www.reliableresearchreports.com/enquiry/pre-order-enquiry/1671438">https://www.reliableresearchreports.com/enquiry/pre-order-enquiry/1671438</a></p>
<p>&nbsp;</p>
<p><strong>Market Segmentation</strong></p>
<p><strong>The Drug Eluting Balloon for Peripheral Artery Disease Market Analysis by types is segmented into:</strong></p>
<p><ul><li>3μg/ mm2</li><li>2μg/ mm2</li><li>Others</li></ul></p>
<p><p>Drug Eluting Balloon for Peripheral Artery Disease market is segmented based on the drug dosage released by the balloon. The market types include 3μg/mm2, 2μg/mm2, and Others. The 3μg/mm2 market type releases a higher dosage of drug compared to the 2μg/mm2 market type, leading to potentially better treatment outcomes. The Others market type may include variations in drug dosage or types not falling under the specified categories. These distinctions cater to the varying needs and preferences of physicians and patients.</p></p>
<p><strong>Purchase this Report:&nbsp;</strong><a href="https://www.reliableresearchreports.com/purchase/1671438">https://www.reliableresearchreports.com/purchase/1671438</a></p>
<p>&nbsp;</p>
<p><strong>The Drug Eluting Balloon for Peripheral Artery Disease Market Industry Research by Application is segmented into:</strong></p>
<p><ul><li>Hospitals</li><li>Ambulatory Surgery Centers</li><li>Catheterization Laboratories</li><li>Others</li></ul></p>
<p><p>Drug Eluting Balloons (DEBs) for Peripheral Artery Disease are used in various healthcare settings such as Hospitals, Ambulatory Surgery Centers, Catheterization Laboratories, and others. Hospitals utilize DEBs for treating patients with PAD through minimally invasive procedures. Ambulatory Surgery Centers also provide these treatments in an outpatient setting. Catheterization Laboratories perform procedures using DEBs to improve blood flow in affected arteries. Other settings like clinics and specialty care facilities also incorporate DEBs for PAD treatment.</p></p>
<p>&nbsp;</p>
<p><strong>In terms of Region, the Drug Eluting Balloon for Peripheral Artery Disease Market Players available by Region are:</strong></p>
<p>
    <p> <strong> North America: </strong>
        <ul>
            <li>United States</li>
            <li>Canada</li>
        </ul>
        </p> 
    <p> <strong> Europe: </strong>
        <ul>
            <li>Germany</li>
            <li>France</li>
            <li>U.K.</li>
            <li>Italy</li>
            <li>Russia</li>
        </ul>
        </p> 
    <p> <strong> Asia-Pacific: </strong>
        <ul>
            <li>China</li>
            <li>Japan</li>
            <li>South Korea</li>
            <li>India</li>
            <li>Australia</li>
            <li>China Taiwan</li>
            <li>Indonesia</li>
            <li>Thailand</li>
            <li>Malaysia</li>
        </ul>
        </p> 
    <p> <strong> Latin America: </strong>
        <ul>
            <li>Mexico</li>
            <li>Brazil</li>
            <li>Argentina Korea</li>
            <li>Colombia</li>
        </ul>
        </p> 
    <p> <strong> Middle East & Africa: </strong>
        <ul>
            <li>Turkey</li>
            <li>Saudi</li>
            <li>Arabia</li>
            <li>UAE</li>
            <li>Korea</li>
        </ul>
    </p>
    </p>
<p><p>The market for drug eluting balloons for peripheral artery disease is projected to witness robust growth across various regions. North America is expected to dominate the market with a projected market share of 45%, followed by Europe with 30% market share, and Asia Pacific with 15% market share. The USA and China are also anticipated to witness significant growth in the market, contributing 5% each to the overall market valuation.</p></p>
<p><strong>Purchase this Report: </strong><a href="https://www.reliableresearchreports.com/purchase/1671438">https://www.reliableresearchreports.com/purchase/1671438</a></p>
<p>&nbsp;<strong>Get a Sample PDF of the Report:&nbsp;&nbsp;</strong><a href="https://www.reliableresearchreports.com/enquiry/request-sample/1671438">https://www.reliableresearchreports.com/enquiry/request-sample/1671438</a></p>
<p><strong></strong></p>
<p>Check more reports on https://www.reliableresearchreports.com/</p>